Recall Alert: 13.5K Bottles of Blood Pressure Med Recalled Nationwide; Riverview Residents Urged to Check

Riverview residents using certain blood pressure medications should check their prescriptions following a nationwide recall of over 13,500 bottles of chlorthalidone tablets. The Food and Drug Administration (FDA) announced the recall of the medication, manufactured by Inventia Healthcare Limited, due to the tablets failing dissolution specifications.

This recall directly impacts local pharmacies and patients who may have received the affected medication. The chlorthalidone tablets, a 25mg dose sold in 100-count bottles, were distributed nationwide. The specific product carries NDC number 64980-599-01, batch number RISA24002, and an expiration date of April 2027.

The FDA initially issued the recall on September 3 and classified it as a Class II recall on September 17. A Class II recall indicates that exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious adverse health consequences is remote. Chlorthalidone is a diuretic, or water pill, used to treat high blood pressure and fluid retention caused by conditions such as congestive heart failure, severe liver disease, or kidney disease.

This is not the first time chlorthalidone has faced recall due to dissolution issues. In June, a similar recall involved chlorthalidone medication distributed by Rising Pharma Holdings, also for failing dissolution specifications. Patients who have the recalled medication should contact their pharmacy or healthcare provider for guidance on returning the product and obtaining a replacement.